Single dose of Dengvaxia vaccine: is it a cause for alarm?

Buerano, Corazon C; Morita, Kouchi

Buerano, Corazon C; Morita, Kouchi.

Afiliação

Buerano CC; Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine Nagasaki University, Sakamoto, Nagasaki City, Nagasaki 852-8523, Japan. Electronic address: ccbuerano@nagasaki-u.ac.jp.
Morita K; Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine Nagasaki University, Sakamoto, Nagasaki City, Nagasaki 852-8523, Japan; Department of Virology, Institute of Tropical Medicine Nagasaki University, Sakamoto, Nagasaki City, Nagasaki 852-8523, Japan; Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance, Nagasaki University, Sakamoto, Nagasaki City, Nagasaki, Japan.

Lancet Infect Dis ; 24(7): 670-671, 2024 Jul.

Article em En | MEDLINE | ID: mdl-38527473

Assuntos

Vacinas contra Dengue; Humanos; Vacinas contra Dengue/administração & dosagem; Vacinas contra Dengue/efeitos adversos; Vacinas contra Dengue/imunologia; Dengue/prevenção & controle; SARS-CoV-2/imunologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Dengue Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google